Stirling Products Limited
ASX:STI ISIN:AU000000STI8
Stirling Products recently acquired a Canadian company Progressive BioActives Incorporated (PBI) under its North American subsidiary, Stirling Products NA Inc. PBI is part of the Bioscience cluster established on located Prince Edward Island, Canada. PBI's lead product ProVale, is the latest high purity beta glucan extract that has been designed as an alternative tool for sustainable livestock management in face of increasing viral disease challenges where antibiotics have no or limited application. ProVale is available for targeted applications in swine, poultry and farmed aquaculture with a future focus on further developing applications for companion animals (e.g. horses, dogs, cats and reptiles).
News
Stirling Products (ASX: STI) advises that it has received written notification of registration approval under the new Feeds Act classification for Yeast Cell Wall Beta Glucan products by the Canadian Food Inspection Agency (CFIA). The two products, ProVale Yeast Cell Wall for Livestock Feeds and ProVale Yeast Cell Wall Premix for Livestock Feeds are now recognized as containing an independently validated and minimum quantity of activated beta glucan from purified yeast cell wall material under the recently amended guidelines implemented by the CFIA.
Stirling Products (ASX: STI) advises that it has recently received information from its current Distribution partner in South Africa (Afgri Operations Pty Limited) that the MCC has approved the application for R-salbutamol to be included under Section 36 of the Stock Remedy Act. The approval means that Afgri, on behalf of Stirling Products, can now conduct the necessary trials for registration and commercialisation under this Act rather than the more stringent MCC process."
The Directors of Stirling Products Limited (ASX: STI) are pleased to announce that the Company has completed a private placement of 42,770,000 fully paid ordinary shares at $0.05 raising A$2,138,500 million. The placement of these shares was approved by Shareholders at the Company's Annual General Meeting held on 22 November, 2007.
Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed discussions and signed a Material Transfer Agreement (MTA) with Pharmswell Co Ltd., based in Seoul, South Korea. The MTA covers the supply of the product ProVale(tm), from its Canadian facility.
Stirling Products (ASX: STI) advises that Stirling Products North America Incorporated (STI-NA) has completed the first phase of the manufacturing scale-up at its Charlottetown facility. The increase in production will satisfy future demands for its newly acquired product ProVale(tm), manufactured at the facility.
Stirling Products Limited (ASX: STI) - 2007 Annual General Meeting - Dr Calvin London, MD; Stirling Products Limited (ASX: STI) present the following audio webcast regarding "2007 Annual General Meeting".
Stirling Products (ASX: STI) advises that, following an announcement last week by the Canadian retailer Co-op Atlantic and its partner the Natural Organic Food Group (NOFG) that they will commence selling Omega-3 enhanced pork products, Stirling Products North America (SPNA) expects increased distribution sales revenue from its Omega-3 premix supplied to the partnership. SPNA, based on Prince Edward Island, Canada, has the exclusive rights to distribute the Omega-3 premix which is currently manufactured to proprietary specifications by KenPal Inc., a leading Canadian supplier of custom premixes and nutritional supplements.
Stirling Products (ASX: STI) advises that it has successfully signed a Letter of Intent (LOI) and finalised a Term Sheet with a leading and progressive USA nutritional feed premix manufacturer and distributor.
Stirling Products Limited (ASX: STI) advises shareholders that studies recently conducted at the University of Western Australia have confirmed the superior biological potency of R-salbutamol over racemic salbutamol.
Stirling Products Limited (ASX: STI) - Activities Update - Dr Calvin London, MD; Stirling Products Limited (ASX: STI) present the following audio webcast regarding "Activities Update". You may also download this audio webcast to your computer or portable audio player.
13,239 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 27) (Last 30 Days: 132) (Since Published: 13239)